ReviewRadiologie (Heidelberg, Germany)2026
[Pediatric sarcomas].
Review in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
clinical/methodological issuePediatric sarcomas representing a rare, heterogenous group of highly malignant tumors. Due to their aggressiveness and complex anatomy during growth, precise imaging is essential for prognosis. STANDARD RADIOLOGIC
methodsMagnetic resonance imaging (MRI), using specific pediatric protocols (small field of view [FOV], thin slices), is the gold standard for local staging. Ultrasound is pivotal for primary diagnosis and biopsy planning, while low-dose chest computed tomography (CT) is used to assess pulmonary metastases. METHODOLOGICAL INNOVATIONS: Diffusion-weighted MRI and positron-emission tomography (PET)/MRI represents a low-radiation and highly efficient alternative to PET/CT for whole-body staging, especially for long-term aftercare. PERFORMANCE: Imaging enables precise delineation of neurovascular structures and growth plates, forming the basis for limb-sparing surgical procedures. However, differentiating between vital residual tumor, recurrence, and posttherapeutic changes (scars, edema) remains challenging. ACHIEVEMENTS: The consistent application of standardized study protocols and the interdisciplinary integration of radiology, oncology, and surgery are crucial for the success of modern therapeutic concepts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.